Viracept nelfinavir mesylate data

AGPH reported results from two trials at the International Conference on Antiviral Research in Atlanta.

In the first trial, after 10 months of

Read the full 235 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE